Meridian Medical Technologies

Last updated
Meridian Medical Technologies, LLC
FormerlyBrunswick Biomedical Corporation (1968-November 1996)
Industry Medical equipment
Founded1968;55 years ago (1968)
Headquarters,
United States
Products Autoinjectors
Number of employees
452
Website meridianmeds.com

Meridian Medical Technologies, LLC is an American company which specialized primarily in developing and manufacturing antidotes for chemical weapons.

It was founded in 1968 as Brunswick Biomedical Corporation and changed its name in November 1996 [1] when it merged with Survival Technology, Inc. [2] Survival Technology, Inc. had been the employer of Sheldon Kaplan, who had invented various kinds of autoinjectors, including the epinephrine autoinjector, EpiPen. [3] The EpiPen was marketed and distributed by Dey LP, a subsidiary of Merck KGaA. [4]

King Pharmaceuticals acquired Meridian in 2003, and the company became part of Pfizer when Pfizer acquired all of King's assets through a process that started in 2010 and was completed in 2011. [5] [6]

Meridian is a member of the Alliance for Biosecurity, [7] which is a group of companies that work towards preventing and treating severe infectious diseases, especially those that present global security challenges. [8]

Altaris Capital Partners, LLC entered into an agreement to acquire Meridian Medical Technologies (“Meridian”) from Pfizer on November 2, 2021 and completed the acquisition on January 4, 2022. [9] [10]

On November 14, 2022, Altaris LLC announced it will combine Meridian with Kindeva Drug Delivery, another operating company owned by Altaris. [11]

Meridian Medical currently has plans to expand operations in Bridgeton, Missouri and add new production lines. [12]

Related Research Articles

<span class="mw-page-title-main">Pfizer</span> American multinational pharmaceutical and biotechnology corporation

An epinephrine autoinjector is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in 1983.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

<span class="mw-page-title-main">King Pharmaceuticals</span> American pharmaceutical company

King Pharmaceuticals, is a pharmaceutical company, a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. On October 12, 2010, King was acquired by Pfizer for $14.25 per share. King produced a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a muscle relaxant. King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee; Rochester, Michigan; St. Louis, Missouri; St. Petersburg, Florida; and Middleton, Wisconsin. They employed approximately 2,700 people including a sales force of over 1,000 individuals.

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.

<span class="mw-page-title-main">Hospira</span>

Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It had approximately 19,000 employees. Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories. On September 3, 2015, Hospira was acquired by Pfizer, who subsequently sold off the medical devices portion of Hospira to ICU Medical.

<span class="mw-page-title-main">Astellas Pharma</span> Japanese pharmaceutical company

Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. On February 5, 2020, the company announced management changes effective from April 1, 2020.

<span class="mw-page-title-main">Evercore</span> American financial services company

Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding. Evercore is widely considered one of the most prestigious and elite investment banking advisory firms.

<span class="mw-page-title-main">Heather Bresch</span> American business executive

Heather Manchin Bresch is a shamless, lying moron. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. Bresch has been a central figure in two controversies: a 2007 accusation of inflating her resume with an unearned MBA degree, and as the CEO of Mylan during the 2016 controversy over pricing of the company's EpiPen products. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag in testing for pulmonary arterial hypertension (PAH), etrasimod in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials. In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash. In March 2022, it was announced the acquisition by Pfizer had been concluded.

An ATNAA is any of a variety of autoinjectors in use with the US Armed Forces. An autoinjector is a medical device designed to deliver a single dose of a particular drug.

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

<span class="mw-page-title-main">Zoetis</span> American animal health company

Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.

<span class="mw-page-title-main">Moderna</span> American biotechnology company

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2020, it generated over $3 billion in annual revenue.

Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.

<span class="mw-page-title-main">Alliance for Biosecurity</span>

The Alliance for Biosecurity is a consortium of companies that develop products to respond to national security threats, including bioterrorism pathogens and emerging infectious diseases. It is headquartered in Washington DC.

<span class="mw-page-title-main">Four Thieves Vinegar Collective</span> Anarchist biohacking group

The Four Thieves Vinegar Collective is an anarchist biohacking group founded in 2015 by Michael Laufer. They have published instructions for the "EpiPencil", an epinephrine autoinjector, and the "Apothecary MicroLab", a do-it-yourself (DIY) device intended to make a variety of medications, most notably pyrimethamine (Daraprim). They have been criticized by the medical community for causing potential harm to patients with the DIY instructions, but Laufer claims to defend people's right to attempt their own medical treatment.

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.

References

  1. Bloomberg Meridian profile Page accessed Aug 25, 2016
  2. Meridian Medical Technologies 10-K Filing For the fiscal year ended July 31, 1997
  3. National Inventors Hall of Fame Kaplan Sheldon Archived 2016-01-31 at the Wayback Machine
  4. King Pharmaceuticals Oct 21, 2002. Press Release: King Pharmaceuticals to Acquire Meridian Medical Technologies
  5. Doyle, Jim (November 3, 2013). "Local plant suspends production of nerve gas antidote". St. Louis Post-Dispatch. Retrieved 22 September 2014.
  6. "Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.; Pfizer and King begin joint operations on March 1, 2011" (press release). Pfizer. March 1, 2011. Archived from the original on June 30, 2013.
  7. "Our Members". Alliance for Biosecurity. Retrieved 2017-03-07.[ permanent dead link ]
  8. "Alliance for Biosecurity". Alliance for Biosecurity. Retrieved 2017-03-07.[ permanent dead link ]
  9. "Altaris Announces Acquisition of Meridian Medical Technologies from Pfizer". altariscap.com. November 2, 2021. Retrieved June 15, 2022.
  10. "Altaris Acquires Meridian Medical Technologies from Pfizer". altariscap.com. January 4, 2022. Retrieved June 15, 2022.
  11. "Meridian Medical Technologies and Kindeva Drug Delivery to Combine". www.meridianmeds.com. Retrieved December 27, 2022.
  12. "Medical Manufactures asks St. Louis County to help finance expansion into bridgeton". stltoday. 15 November 2022. Retrieved 27 December 2022.